These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11802221)

  • 1. Evaluation of cytokeratin-19 mRNA as a tumor marker in the peripheral blood of nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy.
    Lin JC; Chen KY; Wang WY; Jan JS; Liang WM; Wei YH
    Int J Cancer; 2002 Feb; 97(4):548-53. PubMed ID: 11802221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCR detection of circulating tumor cells in nasopharyngeal carcinoma patients with distant metastasis: effect of enzyme and sampling.
    Lin JC; Chen KY; Wang WY; Jan JS; Wei YH
    Head Neck; 2002 Jun; 24(6):591-6. PubMed ID: 12112557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of circulating tumor cells in venous blood of nasopharyngeal carcinoma patients by nested reverse transcriptase-polymerase chain reaction.
    Lin JC; Tsai CS; Wang WY; Jan JS
    Kaohsiung J Med Sci; 2000 Jan; 16(1):1-8. PubMed ID: 10741009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance.
    Stathopoulou A; Vlachonikolis I; Mavroudis D; Perraki M; Kouroussis Ch; Apostolaki S; Malamos N; Kakolyris S; Kotsakis A; Xenidis N; Reppa D; Georgoulias V
    J Clin Oncol; 2002 Aug; 20(16):3404-12. PubMed ID: 12177100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer.
    Xenidis N; Vlachonikolis I; Mavroudis D; Perraki M; Stathopoulou A; Malamos N; Kouroussis C; Kakolyris S; Apostolaki S; Vardakis N; Lianidou E; Georgoulias V
    Ann Oncol; 2003 Jun; 14(6):849-55. PubMed ID: 12796021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular detection of disseminated tumor cells in the peripheral blood of patients with gastric cancer: evaluation of their prognostic significance.
    Wu CH; Lin SR; Hsieh JS; Chen FM; Lu CY; Yu FJ; Cheng TL; Huang TJ; Huang SY; Wang JY
    Dis Markers; 2006; 22(3):103-9. PubMed ID: 16788243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High false-positive rate of cytokeratin-19 in detecting circulating tumor cells for nasopharyngeal carcinoma.
    Kao RH; Huang LC
    Chang Gung Med J; 2002 Apr; 25(4):238-44. PubMed ID: 12079157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer.
    Bozionellou V; Mavroudis D; Perraki M; Papadopoulos S; Apostolaki S; Stathopoulos E; Stathopoulou A; Lianidou E; Georgoulias V
    Clin Cancer Res; 2004 Dec; 10(24):8185-94. PubMed ID: 15623593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.
    Wang JY; Wu CH; Lu CY; Hsieh JS; Wu DC; Huang SY; Lin SR
    World J Surg; 2006 Jun; 30(6):1007-13. PubMed ID: 16736329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction.
    Burchill SA; Bradbury MF; Pittman K; Southgate J; Smith B; Selby P
    Br J Cancer; 1995 Feb; 71(2):278-81. PubMed ID: 7530983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Epstein-Barr virus DNA in the peripheral-blood cells of patients with nasopharyngeal carcinoma: relationship to distant metastasis and survival.
    Lin JC; Chen KY; Wang WY; Jan JS; Liang WM; Tsai CS; Wei YH
    J Clin Oncol; 2001 May; 19(10):2607-15. PubMed ID: 11352952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival of nasopharyngeal carcinoma patients treated with adjuvant chemotherapy subsequent to conventional radical radiotherapy.
    Prasad U; Wahid MI; Jalaludin MA; Abdullah BJ; Paramsothy M; Abdul-Kareem S
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):648-55. PubMed ID: 12062608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer.
    Okegawa T; Kinjo M; Nutahara K; Higashihara E
    J Urol; 2004 Apr; 171(4):1461-6. PubMed ID: 15017198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
    Wei Z; Zhang Z; Luo J; Li N; Peng X
    J Cancer Res Clin Oncol; 2019 Jul; 145(7):1857-1864. PubMed ID: 31062162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma.
    Kunter U; Buer J; Probst M; Duensing S; Dallmann I; Grosse J; Kirchner H; Schluepen EM; Volkenandt M; Ganser A; Atzpodien J
    J Natl Cancer Inst; 1996 May; 88(9):590-4. PubMed ID: 8609659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
    Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
    Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
    Yie SM; Luo B; Ye NY; Xie K; Ye SR
    Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.
    Chen QY; Wen YF; Guo L; Liu H; Huang PY; Mo HY; Li NW; Xiang YQ; Luo DH; Qiu F; Sun R; Deng MQ; Chen MY; Hua YJ; Guo X; Cao KJ; Hong MH; Qian CN; Mai HQ
    J Natl Cancer Inst; 2011 Dec; 103(23):1761-70. PubMed ID: 22056739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma: interim results from 2 prospective phase 2 clinical trials.
    Kong L; Hu C; Niu X; Zhang Y; Guo Y; Tham IW; Lu JJ
    Cancer; 2013 Dec; 119(23):4111-8. PubMed ID: 24037893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.